Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.56 |
| ▸ | RRM1 | P23921 | 1/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.53 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.53 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.53 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.53 |
| ▸ | MMP8 | P22894 | 1/20 | 0.53 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.49 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.49 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.49 |
| ▸ | FNTA | P49354 | 1/20 | 0.49 |
| ▸ | FNTB | P49356 | 1/20 | 0.49 |
| ▸ | CASP2 | P42575 | 1/20 | 0.48 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.48 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.48 |
| ▸ | NAAA | Q02083 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28303860 | 1.00 | DPP7 (0.56) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL10769236 | 0.88 | EPHX1 (0.61) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL29993833 | 0.85 | EPHX1 (0.57) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL14655297 | 0.84 | USP2 (0.41) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL11059038 | 0.81 | EPHX1 (0.57) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL10629970 | 0.81 | FNTA (0.56) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL6238460 | 0.81 | DPP7 (0.65) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL20707200 | 0.81 | DPP7 (0.65) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL20801620 | 0.81 | DPP7 (0.65) | DPP7RRM1EPHX1GNAI3GNAO1 | |
| SCHEMBL6413585 | 0.81 | DPP7 (0.65) | DPP7RRM1EPHX1GNAI3GNAO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040254241-A1 | Enzyme inhibitor; cognition activators | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2004-12-16 | — | — | US | disclosed |
| EP-1431280-A1 | ARYL SULFAMATE DERIVATIVES | Kyowa Hakko Kogyo Co., Ltd (JP) | 2004-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254241-A1 | Enzyme inhibitor; cognition activators | SULT1A1, STS, CYP26A1 | DPP7 1011/4885RRM1 643/4885EPHX1 1677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.